The DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.
A Time to Kill: Targeting Apoptosis in Cancer
Open accessAbstract
The process of apoptosis is essential for maintaining the physiologic balance between cell death and cell growth. This complex process is executed by two major pathways that participate in activating an executioner mechanism leading to chromatin disintegration and nuclear fragmentation. Dysregulation of these pathways often contributes to cancer development and resistance to cancer therapy. Here, we review the most recent discoveries in apoptosis regulation and possible mechanisms for resensitizing tumor cells to therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Chen, W., Li, N., Chen, T., Han, Y., Li, C., Wang, Y., He, W., Zhang, L., Wan, T. Y., & Cao, X. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m502190200 · Cited by 86
RetractedRepertoires of Autophagy in the Pathogenesis of Ocular Diseases
Li, Y.-J., Jiang, Q., Cao, G.-F., Yao, J., & Yan, B. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373980 · Cited by 16,304
The BCL-2 protein family: opposing activities that mediate cell death
Youle, R. J., & Strasser, A. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2308 · Cited by 4,679
The Bcl2 family: regulators of the cellular life-or-death switch
Cory, S., & Adams, J. M. (2002) · Nature Reviews Cancer · doi:10.1038/nrc883 · Cited by 4,032
Proapoptotic BAX and BAK: A Requisite Gateway to Mitochondrial Dysfunction and Death
Wei, M. C., Zong, W.-X., Cheng, E. H.-Y., Lindsten, T., Panoutsakopoulou, V., Ross, A. J., Roth, K. A., MacGregor, G. R., Thompson, C. B., & Korsmeyer, S. J. (2001) · Science · doi:10.1126/science.1059108 · Cited by 3,988
An inhibitor of Bcl-2 family proteins induces regression of solid tumours
Oltersdorf, T., Elmore, S. W., Shoemaker, A. R., Armstrong, R. C., Augeri, D. J., Belli, B. A., Bruncko, M., Deckwerth, T. L., Dinges, J., Hajduk, P. J., et al. (2005) · Nature · doi:10.1038/nature03579 · Cited by 3,416
Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009
Kroemer, G., Galluzzi, L., Vandenabeele, P., Abrams, J., Alnemri, E. S., Baehrecke, E. H., Blagosklonny, M. V., El-Deiry, W. S., Golstein, P., Green, D. R., et al. (2009) · Cell Death & Differentiation · doi:10.1038/cdd.2008.150 · Cited by 3,399
Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy
Czabotar, P. E., Lessene, G., Strasser, A., & Adams, J. M. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3722 · Cited by 3,219
A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma
Ambrosini, G., Adida, C., & Altieri, D. C. (1997) · Nature Medicine · doi:10.1038/nm0897-917 · Cited by 3,165
Discovery and saturation analysis of cancer genes across 21 tumour types
Lawrence, M. S., Stojanov, P., Mermel, C. H., Robinson, J. T., Garraway, L. A., Golub, T. R., Meyerson, M., Gabriel, S. B., Lander, E. S., & Getz, G. (2014) · Nature · doi:10.1038/nature12912 · Cited by 3,096
ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets
Souers, A. J., Leverson, J. D., Boghaert, E. R., Ackler, S. L., Catron, N. D., Chen, J., Dayton, B. D., Ding, H., Enschede, S. H., Fairbrother, W. J., et al. (2013) · Nature Medicine · doi:10.1038/nm.3048 · Cited by 3,058
Death and anti-death: tumour resistance to apoptosis
Igney, F. H., & Krammer, P. H. (2002) · Nature Reviews Cancer · doi:10.1038/nrc776 · Cited by 2,075
ABT-263: A Potent and Orally Bioavailable Bcl-2 Family Inhibitor
Tse, C., Shoemaker, A. R., Adickes, J., Anderson, M. G., Chen, J., Jin, S., Johnson, E. F., Marsh, K. C., Mitten, M. J., Nimmer, P., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5836 · Cited by 1,992
RIP3, an Energy Metabolism Regulator That Switches TNF-Induced Cell Death from Apoptosis to Necrosis
Zhang, D.-W., Shao, J., Lin, J., Zhang, N., Lu, B.-J., Lin, S.-C., Dong, M.-Q., & Han, J. (2009) · Science · doi:10.1126/science.1172308 · Cited by 1,931
Lysosomal membrane permeabilization in cell death
Boya, P., & Kroemer, G. (2008) · Oncogene · doi:10.1038/onc.2008.310 · Cited by 1,426
Rampino, N., Yamamoto, H., Ionov, Y., Li, Y., Sawai, H., Reed, J. C., & Perucho, M. (1997) · Science · doi:10.1126/science.275.5302.967 · Cited by 1,326
Calpain-mediated cleavage of Atg5 switches autophagy to apoptosis
Yousefi, S., Perozzo, R., Schmid, I., Ziemiecki, A., Schaffner, T., Scapozza, L., Brunner, T., & Simon, H.-U. (2006) · Nature Cell Biology · doi:10.1038/ncb1482 · Cited by 1,158
Functional and physical interaction between Bcl‐XL and a BH3‐like domain in Beclin‐1
Maiuri, M. C., Le Toumelin, G., Criollo, A., Rain, J., Gautier, F., Juin, P., Tasdemir, E., Pierron, G., Troulinaki, K., Tavernarakis, N., et al. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601689 · Cited by 1,105
The coordinate release of cytochrome c during apoptosis is rapid, complete and kinetically invariant
Goldstein, J. C., Waterhouse, N. J., Juin, P., Evan, G. I., & Green, D. R. (2000) · Nature Cell Biology · doi:10.1038/35004029 · Cited by 1,071
Promiscuous Mutations Activate the Noncanonical NF-κB Pathway in Multiple Myeloma
Keats, J. J., Fonseca, R., Chesi, M., Schop, R., Baker, A., Chng, W.-J., Van Wier, S., Tiedemann, R., Shi, C.-X., Sebag, M., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.07.003 · Cited by 983
Annunziata, C. M., Davis, R. E., Demchenko, Y., Bellamy, W., Gabrea, A., Zhan, F., Lenz, G., Hanamura, I., Wright, G., Xiao, W., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.07.004 · Cited by 952
Cleavage of the death domain kinase RIP by Caspase-8 prompts TNF-induced apoptosis
Lin, Y., Devin, A., Rodriguez, Y., & Liu, Z.-G. (1999) · Genes & Development · doi:10.1101/gad.13.19.2514 · Cited by 836
Roberts, A. W., Seymour, J. F., Brown, J. R., Wierda, W. G., Kipps, T. J., Khaw, S. L., Carney, D. A., He, S. Z., Huang, D. C. S., Xiong, H., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.34.7898 · Cited by 830
IAPs: from caspase inhibitors to modulators of NF-κB, inflammation and cancer
Gyrd-Hansen, M., & Meier, P. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2889 · Cited by 790
The lysosome: from waste bag to potential therapeutic target
Appelqvist, H., Wäster, P., Kågedal, K., & Öllinger, K. (2013) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjt022 · Cited by 772 · cited 1×
“LMP results from different signals, such as death receptors, reactive oxygen species (ROS), ultraviolet radiation, proteasome inhibition, growth deprivation and p53 activation [28–30].”
BackgroundApoptosis and cancer: mutations within caspase genes
Ghavami, S., Hashemi, M., Ande, S. R., Yeganeh, B., Xiao, W., Eshraghi, M., Bus, C. J., Kadkhoda, K., Wiechec, E., Halayko, A. J., et al. (2009) · Journal of Medical Genetics · doi:10.1136/jmg.2009.066944 · Cited by 713
Foghsgaard, L., Wissing, D., Mauch, D., Lademann, U., Bastholm, L., Boes, M., Elling, F., Leist, M., & Jäättelä, M. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.153.5.999 · Cited by 629
Cellular Mechanisms Controlling Caspase Activation and Function
Parrish, A. B., Freel, C. D., & Kornbluth, S. (2013) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a008672 · Cited by 625
Mitochondrial Regulation of Cell Death
Tait, S. W. G., & Green, D. R. (2013) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a008706 · Cited by 530
IAP-targeted therapies for cancer
LaCasse, E. C., Mahoney, D. J., Cheung, H. H., Plenchette, S., Baird, S., & Korneluk, R. G. (2008) · Oncogene · doi:10.1038/onc.2008.302 · Cited by 524
Death receptors in chemotherapy and cancer
Debatin, K.-M., & Krammer, P. H. (2004) · Oncogene · doi:10.1038/sj.onc.1207558 · Cited by 505
Regulation of apoptosis-associated lysosomal membrane permeabilization
Johansson, A.-C., Appelqvist, H., Nilsson, C., Kågedal, K., Roberg, K., & Öllinger, K. (2010) · Apoptosis · doi:10.1007/s10495-009-0452-5 · Cited by 463
Apoptosis: The Molecular Basis of Cell Death
Tomei, L., & Cope, F. O. (1991) · Medical Entomology and Zoology · Cited by 438
Regulation of the Apaf-1–caspase-9 apoptosome
Bratton, S. B., & Salvesen, G. S. (2010) · Journal of Cell Science · doi:10.1242/jcs.073643 · Cited by 433
Martins, L. M., Morrison, A., Klupsch, K., Fedele, V., Moisoi, N., Teismann, P., Abuin, A., Grau, E., Geppert, M., Livi, G. P., et al. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.22.9848-9862.2004 · Cited by 394
Loss of Omi mitochondrial protease activity causes the neuromuscular disorder of mnd2 mutant mice
Jones, J. M., Datta, P., Srinivasula, S. M., Ji, W., Gupta, S., Zhang, Z., Davies, E., Hajnóczky, G., Saunders, T. L., Van Keuren, M. L., et al. (2003) · Nature · doi:10.1038/nature02052 · Cited by 377
Cancer gene therapy using a survivin mutant adenovirus
Mesri, M., Wall, N. R., Li, J., Kim, R. W., & Altieri, D. C. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12983 · Cited by 337
Inhibitor of Apoptosis (IAP) Proteins-Modulators of Cell Death and Inflammation
Silke, J., & Meier, P. (2013) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a008730 · Cited by 332
The Bcl-2 specific BH3 mimetic ABT-199: a promising targeted therapy for t(11;14) multiple myeloma
Touzeau, C., Dousset, C., Le Gouill, S., Sampath, D., Leverson, J. D., Souers, A. J., Maïga, S., Béné, M. C., Moreau, P., Pellat-Deceunynck, C., et al. (2014) · Leukemia · doi:10.1038/leu.2013.216 · Cited by 289
Cell surface Death Receptor signaling in normal and cancer cells
Özören, N., & El-Deiry, W. S. (2003) · Seminars in Cancer Biology · doi:10.1016/s1044-579x(02)00131-1 · Cited by 289
Iqbal, J., Sanger, W. G., Horsman, D. E., Rosenwald, A., Pickering, D. L., Dave, B., Dave, S., Xiao, L., Cao, K., Zhu, Q., et al. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63284-1 · Cited by 279
Targeting BCL-2 with the BH3 Mimetic ABT-199 in Estrogen Receptor-Positive Breast Cancer
Vaillant, F., Merino, D., Lee, L., Breslin, K., Pal, B., Ritchie, M. E., Smyth, G. K., Christie, M., Phillipson, L. J., Burns, C. J., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.06.002 · Cited by 276
Bak Activation for Apoptosis Involves Oligomerization of Dimers via Their α6 Helices
Dewson, G., Kratina, T., Czabotar, P., Day, C. L., Adams, J. M., & Kluck, R. M. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.11.008 · Cited by 220
New frontiers in promoting tumour cell death: targeting apoptosis, necroptosis and autophagy
Long, J. S., & Ryan, K. M. (2012) · Oncogene · doi:10.1038/onc.2012.7 · Cited by 214
Roulland, S., Navarro, J.-M., Grenot, P., Milili, M., Agopian, J., Montpellier, B., Gauduchon, P., Lebailly, P., Schiff, C., & Nadel, B. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061292 · Cited by 207
Mérino, D., Khaw, S. L., Glaser, S. P., Anderson, D. J., Belmont, L. D., Wong, C., Yue, P., Robati, M., Phipson, B., Fairlie, W. D., et al. (2012) · Blood · doi:10.1182/blood-2011-12-400929 · Cited by 192
Vandenberg, C. J., & Cory, S. (2013) · Blood · doi:10.1182/blood-2013-01-475855 · Cited by 191
Unleashing the power of inhibitors of oncogenic kinases through BH3 mimetics
Cragg, M. S., Harris, C., Strasser, A., & Scott, C. L. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2615 · Cited by 185
Cell division and cell survival in the absence of survivin
Yang, D., Welm, A., & Bishop, J. M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0406665101 · Cited by 177
Generation and Characterization of Smac/DIABLO-Deficient Mice
Okada, H., Suh, W.-K., Jin, J., Woo, M., Du, C., Elia, A., Duncan, G. S., Wakeham, A., Itie, A., Lowe, S. W., et al. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.10.3509-3517.2002 · Cited by 173
Vural, D. F., Cebesoy, S., & Karakaş, M. F. (2013) · Journal of Entomology and Zoology Studies · Cited by 172
Preferential linkage of bcl-2 to immunoglobulin light chain gene in chronic lymphocytic leukemia.
Adachi, M., Tefferi, A., Greipp, P. R., Kipps, T. J., & Tsujimoto, Y. (1990) · The Journal of experimental medicine · doi:10.1084/jem.171.2.559 · Cited by 164
Jäger, U., Böcskör, S., Le, T., Mitterbauer, G., Bolz, I., Chott, A., Kneba, M., Mannhalter, C., & Nadel, B. (2000) · Blood · doi:10.1182/blood.v95.11.3520 · Cited by 161
Regulation of death receptor signaling by the ubiquitin system
Wertz, I. E., & Dixit, V. M. (2009) · Cell Death and Differentiation · doi:10.1038/cdd.2009.168 · Cited by 159
Targeting mitochondrial factor Smac/DIABLO as therapy for multiple myeloma (MM)
Chauhan, D., Neri, P. E., Velankar, M., Podar, K., Hideshima, T., Fulciniti, M., Tassone, P., Raje, N. S., Mitsiades, C. S., Mitsiades, N., et al. (2006) · Blood · doi:10.1182/blood-2006-04-015149 · Cited by 151
Substrates of IAP Ubiquitin Ligases Identified with a Designed Orthogonal E3 Ligase, the NEDDylator
Zhuang, M., Guan, S., Wang, H., Burlingame, A. L., & Wells, J. A. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.10.022 · Cited by 144
Byun, D.-S., Cho, K., Ryu, B., Lee, M. G., Kang, M. J., Kim, H. R., & Chi, S. (2003) · PubMed · Cited by 134
Smac mimetics as new cancer therapeutics
Chen, D. J., & Huerta, S. (2009) · Anti-Cancer Drugs · doi:10.1097/cad.0b013e32832ced78 · Cited by 132
The role of NF-κB-1 and NF-κB-2-mediated resistance to apoptosis in lymphomas
Bernal‐Mizrachi, L., Lovly, C. M., & Ratner, L. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507809103 · Cited by 129
Self-citationSteinhart, L., Belz, K., & Fulda, S. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.320 · Cited by 124
IAPs, regulators of innate immunity and inflammation
Estornes, Y., & Bertrand, M. J. M. (2014) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2014.03.035 · Cited by 116
Navitoclax Enhances the Efficacy of Taxanes in Non–Small Cell Lung Cancer Models
Tan, N., Malek, M., Zha, J., Peng, Y., Kassees, R., Berry, L., Fairbrother, W. J., Sampath, D., & Belmont, L. D. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2353 · Cited by 116
IAP antagonists: promising candidates for cancer therapy
Mannhold, R., Fulda, S., & Carosati, E. (2010) · Drug Discovery Today · doi:10.1016/j.drudis.2010.01.003 · Cited by 98
Weisberg, E., Kung, A. L., Wright, R. D., Moreno, D., Catley, L., Ray, A., Zawel, L. S., Tran, M., Cools, J., Gilliland, G. D., et al. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0810 · Cited by 79
Inactivating mutations of proapoptotic Bad gene in human colon cancers
Lee, J. W., Soung, Y. H., Nam, S. W., Nam, S. W., Kim, C. J., Cho, Y. G., Lee, J. H., Kim, S. H., Park, W. S., Kim, S. Y., et al. (2004) · Carcinogenesis · doi:10.1093/carcin/bgh145 · Cited by 71
Yang, J., McEachern, D., Li, W., Davis, M. A., Li, H., Morgan, M. A., Bai, L., Sebolt, J. T., Sun, H., Lawrence, T. S., et al. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0643 · Cited by 56
Belz, K., Schoeneberger, H., Wehner, S., Weigert, A., Bonig, H. B., Klingebiel, T., Fichtner, I., & Fulda, S. (2014) · Blood · doi:10.1182/blood-2013-05-500918 · Cited by 51
Sheng, R., Sun, H., Liu, L., Lü, J., McEachern, D., Wang, G., Wen, J., Min, P., Du, Z., Lu, H., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm400216d · Cited by 40
Zhang, S., Li, G., Zhao, Y., Liu, G., Wang, Y., Ma, X.-X., Li, D., Wu, Y., & Lü, J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051461 · Cited by 27
Ramachandiran, S., Cain, J., Liao, A., et al. (2012) · Leukemia Research · doi:10.1016/j.leukres.2011.12.024 · Cited by 8
Self-citation
Cited by
Nedeljković, M., & Damjanović, A. (2019) · Cells · doi:10.3390/cells8090957 · Cited by 870
Mechanisms of apoptosis modulation by curcumin: Implications for cancer therapy
Mortezaee, K., Salehi, E., Mirtavoos‐mahyari, H., Motevaseli, E., Najafi, M., Farhood, B., Rosengren, R. J., & Sahebkar, A. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28122 · Cited by 340
Characterization and anti-tumor bioactivity of astragalus polysaccharides by immunomodulation
Li, W., Hu, X., Wang, S., Jiao, Z., Sun, T., Liu, T., & Song, K. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2019.09.189 · Cited by 277
Metadata
- Authors
- Koff, J., Ramachandiran, S., & Bernal-Mizrachi, L.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2015-01-28
- Volume
- 16
- Issue
- 2
- Pages
- 2942-2955
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W1988398656
- Cited by
- 279
- References
- 70
- FWCI
- 13.51
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.